New York, United States
Castor, founded in 2011, is a pioneering entity in integrating technology with clinical research. The company's mantra, "Real-world ready. Remote-first. AI-powered," underscores its commitment to making patient-centered clinical trials accessible globally through technological innovation.
Operating in the Health Care, Health and Wellness, and Pharmaceutical industries, Castor offers a modular clinical trial platform. This platform streamlines trial design, patient engagement, data collection, and result analysis, boasting customizable modules tailored to user needs. This flexibility benefits patients, research teams, and sponsors alike, enhancing the historical barriers in trial management.
The company, headquartered in the United States, secured a $45.00M Series B investment on July 14, 2021. Notable investors include Two Sigma Ventures, Eight Roads Ventures, F-Prime Capital, and Inkef, reflecting substantial confidence in Castor's potential to redefine the clinical research landscape.
